Search Within

Semanti Mukherjee

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (10)
Groups
  1. Alumni (GSK) (27)
  2. Clinical Genetics Service (27)
  3. Department of Medicine (27)
  4. GSK Faculty (27)
  5. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (27)
  6. Human Oncology and Pathogenesis Program (27)

More Groups

People
  1. Kenneth Offit (24)
  2. Michael Berger (21)
  3. Zsofia Stadler (20)
  4. Diana Mandelker (19)
  5. Yelena Kemel (19)
  6. Mark Robson (18)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. JCO Precision Oncology (3)
  3. Cancer Epidemiology Biomarkers and Prevention (2)
  4. Cancer Research (2)
  5. Clinical Cancer Research (2)
  6. Nature Genetics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (7)
  3. Nature Publishing Group (3)
  4. American Medical Association (2)
  5. American Association for the Advancement of Science (1)
  6. American Society of Hematology (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Carlo, M. I.; Mukherjee, S.; Kemel, Y.; Zhang, L.; Mandelker, D.; Vijai, J.; Coskey, D. T.; Pradhan, N.; Hyman, D. M.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2 V617f-positive myeloproliferative neoplasms
    Meeting Abstract

    Kilpivaara, O.; Mukherjee, S.; Schram, A.; Wadleigh, M.; Mullally, A.; Ebert, R.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Haematologica (2009)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms
    Journal Article

    Kilpivaara, O.; Mukherjee, S.; Schram, A. M.; Wadleigh, M.; Mullally, A.; Ebert, B. L.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Nature Genetics (2009)

    Fulltext@MSK | Save